REQUEST A DEMO
Total
USD $0.00
Search more companies

Med & Sul S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Med & Sul S.A. Profile Updated: February 07, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Med & Sul S.A. is based in Ecuador. The head office is in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on March 26, 2018. It currently has a total number of 3 (2024) employees. The company’s latest financial report indicates a net sales revenue drop of 21.05% in 2024. There was a total growth of 120.56% in Med & Sul S.A.’s total assets over the same period. The net profit margin of Med & Sul S.A. decreased by 0.26% in 2024.

Headquarters
Balsamos Sur 116 B
Guayaquil; Guayas;

Contact Details: Purchase the Med & Sul S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Med & Sul S.A. report to view the information.
Registered Capital:
Purchase the Med & Sul S.A. report to view the information.
Financial Auditors:
Purchase the Med & Sul S.A. report to view the information.
Incorporation Date:
March 26, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Resto & Bar Mal de Amores Bar & amor S.A.
40%
Company Performance
Financial values in the chart are available after Med & Sul S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-21.05%
Total operating revenue
-21.05%
Operating Profit/Loss (EBIT)
-24.05%
EBITDA
-0.16%
Net Profit/Loss for the Period
-24.05%
Total Assets
120.56%
Total Equity
5.92%
Operating Profit Margin (ROS)
-0.39%
Net Profit Margin
-0.26%
Return on Equity (ROE)
-2.21%
Quick Ratio
-1.29%
Cash Ratio
0.68%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?